Clinical Trials Insight: 700047791
Phase of Trial: Phase I
Latest Information Update: 17 Aug 2010
At a glance
- Drugs Bremelanotide (Primary)
- Indications Erectile dysfunction
- Focus Adverse reactions
- Sponsors Palatin Technologies
- 17 Aug 2010 Status changed from active, no longer recruiting to completed, according to a Palatin Technologies media release.
- 24 Jun 2010 Top-line data are expected in the third quarter of 2010, according to a Palatin Technologies media release.
- 24 Jun 2010 Palatin Technologies completes patient dosing and database lock, according to a company media release.